Inhibrx Biosciences, Inc. (INBX) key performance indicators and operating metrics (2 metrics) from SEC EDGAR filings, earnings calls, and investor decks. First-party data.
| Metric | Latest Value | Period |
|---|---|---|
| Median Progression-Free Survival | 5.50 | FY2026-Q1 |
| Disease Control Rate (Partial Response or Stable Disease) | 87.00 percent | FY2026-Q1 |
Back to INBX overview · INBX earnings · INBX holders
Data sourced from U.S. SEC EDGAR filings, earnings call transcripts, and investor decks. Not personalized investment advice.